OTC Drug [당뇨병용제]
MEPIRIL Tablet
- Classification
- OTC Drug
- Validity period
- Composition
- One tablet contains Glimepiride 2mg
- Package
OTC Drug
noninsulin-dependent (Type II) diabetes mellitus (NIDDM)
●MEPIRIL is indicated for the treatment of type 2 diabetes mellitus, when diet, physical exercise and weight reduction alone are not adequate.
●Refer to insert-paper for further information.
●MEPIRIL is indicated for the treatment of type 2 diabetes mellitus, when diet, physical exercise and weight reduction alone are not adequate.
●Refer to insert-paper for further information.
●Dosage is determined by the results of blood and urinary glucose determinations.
●The starting dose is 1 mg glimepiride per day.
If control is unsatisfactory the dosage should be increased, based on the glycaemic control, in a stepwise manner with an interval of about 1 to 2 weeks between each step, to 2, 3 or 4 mg glimepiride per day.
●A dosage of more than 4 mg glimepiride per day gives better results only in exceptional cases. The maximum recommended dose is 6 mg glimepiride per day.
●The starting dose is 1 mg glimepiride per day.
If control is unsatisfactory the dosage should be increased, based on the glycaemic control, in a stepwise manner with an interval of about 1 to 2 weeks between each step, to 2, 3 or 4 mg glimepiride per day.
●A dosage of more than 4 mg glimepiride per day gives better results only in exceptional cases. The maximum recommended dose is 6 mg glimepiride per day.
